PEAK6 Investments L.P. increased its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 533.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 64,895 shares of the medical device company’s stock after acquiring an additional 54,643 shares during the period. PEAK6 Investments L.P. owned approximately 0.47% of Cutera worth $2,683,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of CUTR. Legal & General Group Plc increased its holdings in Cutera by 69.6% during the 3rd quarter. Legal & General Group Plc now owns 3,600 shares of the medical device company’s stock worth $149,000 after acquiring an additional 1,477 shares during the period. Nationwide Fund Advisors increased its holdings in Cutera by 8.4% during the 2nd quarter. Nationwide Fund Advisors now owns 7,216 shares of the medical device company’s stock worth $187,000 after acquiring an additional 561 shares during the period. Metropolitan Life Insurance Co. NY bought a new stake in Cutera during the 1st quarter worth approximately $202,000. Greenwood Capital Associates LLC bought a new stake in Cutera during the 3rd quarter worth approximately $210,000. Finally, Cubist Systematic Strategies LLC bought a new stake in Cutera during the 2nd quarter worth approximately $225,000. 87.64% of the stock is currently owned by institutional investors and hedge funds.
Cutera, Inc. (NASDAQ:CUTR) opened at $39.50 on Thursday. The company has a market cap of $536.88, a price-to-earnings ratio of 49.68, a PEG ratio of 1.68 and a beta of 0.53. Cutera, Inc. has a twelve month low of $15.90 and a twelve month high of $47.15.
In related news, Director David B. Apfelberg sold 1,000 shares of the stock in a transaction on Friday, November 17th. The shares were sold at an average price of $42.55, for a total transaction of $42,550.00. Following the transaction, the director now owns 8,055 shares of the company’s stock, valued at approximately $342,740.25. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Ronald J. Santilli sold 5,775 shares of the stock in a transaction on Monday, September 11th. The shares were sold at an average price of $40.43, for a total transaction of $233,483.25. Following the transaction, the chief financial officer now directly owns 50,012 shares in the company, valued at approximately $2,021,985.16. The disclosure for this sale can be found here. Insiders sold a total of 20,725 shares of company stock worth $843,253 in the last three months. Insiders own 3.30% of the company’s stock.
CUTR has been the topic of a number of analyst reports. BidaskClub raised shares of Cutera from a “hold” rating to a “buy” rating in a report on Saturday, August 12th. Gabelli reaffirmed a “buy” rating on shares of Cutera in a report on Wednesday, August 9th. Maxim Group lowered shares of Cutera from a “buy” rating to a “hold” rating in a report on Thursday, September 14th. Zacks Investment Research lowered shares of Cutera from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Finally, TheStreet raised shares of Cutera from a “c” rating to a “b” rating in a report on Friday, August 18th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Cutera currently has an average rating of “Buy” and an average price target of $37.33.
ILLEGAL ACTIVITY NOTICE: This story was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/3078815/peak6-investments-l-p-has-2-68-million-position-in-cutera-inc-cutr.html.
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR).
Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.